Stock Price Quote

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4119.7512.4 (+0.3 %)
PREV CLOSE ( ) 4107.35
OPEN PRICE ( ) 4107.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1064
TODAY'S LOW / HIGH ( )4076.20 4155.00
52 WK LOW / HIGH ( )3702.15 4940
NSE4130.2016.85 (+0.41 %)
PREV CLOSE( ) 4113.35
OPEN PRICE ( ) 4113.35
BID PRICE (QTY) 4130.20 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12557
TODAY'S LOW / HIGH( ) 4075.10 4149.00
52 WK LOW / HIGH ( )3690 5000
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-11 1950
Management Info
Pradip Shah - Chairman Meenakshi Nevatia - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerltd.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

12Apr Intimation Regarding Appointment Of C
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby in..
22Jan Pfizer informs about appointment of ex
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
18Aug Pfizer informs about change in managem
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
20Jul Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..
20Jun Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit1299.86239.3
Gross Profit 1759.4 8240.1
Operating Profit 18849099.1
Net Sales 5399.724247.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

MUTUAL FUNDS/UTI 7.72%
FI/BANKS/INSURANCE 7.45%
PROMOTERS 63.92%
NON-INSTITUTION 17.42%
GOVERNMENT 0%
FII 0%

About Pfizer Ltd.

Pfizer Ltd. was incorporated in the year 1950. Its today's share price is 4119.75. Its current market capitalisation stands at Rs 18846.92 Cr. In the latest quarter, company has reported Gross Sales of Rs. 25602.7 Cr and Total Income of Rs.25258.1 Cr. The company's management includes Uday Khanna, Sunil Lalbhai, Meenakshi Nevatia, Meena Ganesh, Pradip Shah, Prajeet Nair.

It is listed on the BSE with a BSE Code of 500680 , NSE with an NSE Symbol of PFIZER and ISIN of INE182A01018. It's Registered office is at The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East)Mumbai-400051, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AF Ferguson & Co, BSR & Co, BSR & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.